• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Lab Hematol . Relationship of D-dimer with severity and mortality in SARS-CoV-2 patients : A meta-analysis

tetano

Editor, Senior Moderator
Int J Lab Hematol


. 2020 Sep 15.
doi: 10.1111/ijlh.13336. Online ahead of print.
Relationship of D-dimer with severity and mortality in SARS-CoV-2 patients : A meta-analysis


Johanes Nugroho[SUP] 1 2 [/SUP], Ardyan Wardhana[SUP] 3 [/SUP], Irma Maghfirah[SUP] 2 [/SUP], Eka Prasetya Budi Mulia[SUP] 2 [/SUP], Dita Aulia Rachmi[SUP] 2 [/SUP], Maya Qurota A'yun[SUP] 2 [/SUP], Imanita Septianda[SUP] 2 [/SUP]



Affiliations

Abstract

Introduction: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic. Many studies have shown that several laboratory parameters are related to disease severity and mortality in SARS-CoV-2 cases. This meta-analysis aimed to determine the relationship of a prognostic factor, D-dimer, with disease severity, need for intensive care unit (ICU) care, and mortality in SARS-CoV-2 patients.
Methods: A systematic search for all observational studies and trials involving adult patients with SARS-CoV-2 that had any data related to D-dimer on admission was conducted using PubMed, Science Direct, Scopus, ProQuest, and MedRxiv databases. We performed random-effects inverse-variance weighting analysis using mean difference (MD) of D-dimer values for outcomes such as disease severity, mortality, and need for ICU care.
Results: A total of 29 studies (4,328 patients) were included in this meta-analysis, which revealed a higher mean of D-dimer levels on admission in severe patients than in nonsevere patients (MD = 0.95, [95% confidence interval (CI): 0.61-1.28], P < .05; I[SUP]2[/SUP] = 90%). The nonsurvivor group had a higher pooled MD of D-dimer values on admission (MD = 5.54 [95% CI: 3.40-7.67], P < .05; I[SUP]2[/SUP] = 90%). Patients who needed ICU admission had insignificantly higher D-dimer values than patients who did not need ICU admission (MD = 0.29, [95% CI: -0.05 to 0.63], P = .10; I[SUP]2[/SUP] = 71%).
Conclusion: Elevated D-dimer levels on admission were associated with an increased risk of disease severity and mortality in patients with SARS-CoV-2 infection.

Keywords: D-dimer; SARS-CoV-2; laboratory; mortality; prognostic factor; severity.
 
Back
Top Bottom